Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Capital Expenditures: 2019-2024

Historic Capital Expenditures for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $993,000.

  • Mirum Pharmaceuticals' Capital Expenditures rose 3.31% to $187,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $374,000, marking a year-over-year decrease of 64.07%. This contributed to the annual value of $993,000 for FY2024, which is 811.01% up from last year.
  • As of FY2024, Mirum Pharmaceuticals' Capital Expenditures stood at $993,000, which was up 811.01% from $109,000 recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Capital Expenditures registered a high of $993,000 during FY2024, and its lowest value of $24,000 during FY2021.
  • Moreover, its 3-year median value for Capital Expenditures was $278,000 (2022), whereas its average is $460,000.
  • In the last 5 years, Mirum Pharmaceuticals' Capital Expenditures slumped by 89.33% in 2021 and then soared by 1,058.33% in 2022.
  • Mirum Pharmaceuticals' Capital Expenditures (Yearly) stood at $225,000 in 2020, then tumbled by 89.33% to $24,000 in 2021, then soared by 1,058.33% to $278,000 in 2022, then crashed by 60.79% to $109,000 in 2023, then soared by 811.01% to $993,000 in 2024.